Search Results

Displaying Results 9376-9400 of 20918 "'R'"

Apr 30, 2026, 17:58 ET Haier Biomedical est à l'origine d'un essor mondial de l'infrastructure des sciences de la vie : les activités internationales atteignent un niveau record, représentant 36 % du chiffre d'affaires annuel en 2025

énergétique : les huit premiers produits classés dans le programme ENERGY STAR proviennent tous de Haier Biomedical.En 2025, les investissements en R&D de l'entreprise ont atteint 320 millions de yuans (46,82 millions d'USD), et les brevets de nouvelles inventions ont augmenté de 50 % par rapport à

More news about: Haier Biomedical


Apr 30, 2026, 17:48 ET Haier Biomedical stimuleert wereldwijde vooruitgang in de infrastructuur voor de biowetenschappen: Internationaal bedrijf bereikt recordhoogte met 36% van de jaarlijkse omzet in 2025

energie-efficiëntie behaald: de 8 best gerangschikte producten in het ENERGY STAR-programma zijn allemaal van Haier Biomedical.In 2025 bereikte de R&D-investering van het bedrijf 320 miljoen yuan ( 46,82 miljoen USD), met patenten op nieuwe uitvindingen met 50% op jaarbasis tot 1.620 patenten. Het tarief

More news about: Haier Biomedical


Apr 30, 2026, 17:15 ET NUTEX HEALTH REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS

https://callme.viavid.com/viavid/?callme=true&passcode=13746493&h=true&info=company&r=true&B=6To access the call, please dial in approximately five minutes before start time. Those

More news about: Nutex Health, Inc.


Apr 30, 2026, 17:00 ET AGNICO EAGLE REPORTS FIRST QUARTER 2026 RESULTS, INCLUDING RECORD QUARTERLY OPERATING MARGINS AND ADJUSTED NET INCOME

activities are underway.San Nicolás Copper Project (50/50 joint venture with Teck Resources Limited)Regulatory decisions for the MIA-R (Environmental Impact Assessment) and ETJ (Land Use Change) permits are pending. In the first quarter of 2026, Minas de San Nicolás continued to advance

More news about: Agnico Eagle Mines Limited


Apr 30, 2026, 16:48 ET LG&E and KU collaborate with X-energy to explore nuclear energy

in the Commonwealth to help ensure we maintain and build upon our strong competitive energy advantage with reliable and affordable power," said John R. Crockett III, President for LG&E and KU. "On the heels of the Nuclear Reactor Site Readiness Pilot Program being signed into law this month, we're

More news about: LG&E and KU


Apr 30, 2026, 16:47 ET Policymakers and Asset Management Leaders Gather for ICI's 2026 Leadership Summit

Shortly following was an insightful conversation with Senator Ted Cruz (R-TX) and ICI Chief Government Affairs and Public Policy Officer Tom Quaadman. The pair discussed Cruz's perspective on the current legislative priorities

More news about: Investment Company Institute


Apr 30, 2026, 16:20 ET Huntsman Announces Second Quarter 2026 Common Dividend

are sold worldwide to manufacturers serving a broad and diverse range of consumer and industrial end markets. We operate more than 55 manufacturing, R&D and operations facilities in approximately 25 countries and employ approximately 6,000 associates within our continuing operations. For more information

More news about: Huntsman Corporation


Apr 30, 2026, 16:15 ET Huntsman Announces First Quarter 2026 Earnings

loss attributable to Huntsman of $53 million, adjusted net loss attributable to Huntsman of $35 million and adjusted EBITDA of $73 million. Peter R. Huntsman, Chairman, President, and CEO, commented:"The first two months of the first quarter progressed as expected with some early trends

More news about: Huntsman Corporation


Apr 30, 2026, 16:05 ET Illumina Reports Financial Results for First Quarter of Fiscal Year 2026

accomplish our desired operational goals; (xiii) our ability to realize the anticipated benefits from prior or future actions to streamline and improve our R&D processes, reduce our operating expenses and maximize our revenue growth; (xiv) our ability to further develop and commercialize our instruments, consumables,

More news about: Illumina, Inc.


Apr 30, 2026, 16:00 ET FiEE, Inc. Announces First Quarter 2026 Unaudited Financial Results

brand management, generating sales since March 2025. The increase in revenue is also driven by the Company's newly introduced customized software R&D services and digital authentication services.As of March 31, 2026, FiEE onboarded approximately 818 customers for its

More news about: FiEE, Inc.


Apr 30, 2026, 15:49 ET Wegovy® é mais eficiente em preservar massa muscular durante a perda de peso, mostram novos estudos de vida real

Presented at the European Association for the Study of Diabetes (EASD) 61st Annual Meeting, 15–19 September 2025, Vienna, Austria. Katherine R. Tuttle et al. Journal of the American Society of Nephrology 36(10S):10.1681/ASN.2025fdqxb4qe, October 2025. Sanyal AJ et al. N Engl J Med 2025;392(21):2089–99.

More news about: Novo Nordisk


Apr 30, 2026, 14:29 ET Norgine annuncia l'autorizzazione all'immissione in commercio da parte della Commissione europea per XOLREMDI ® (mavorixafor), la prima terapia autorizzata per i pazienti con sindrome WHIM nell'Unione Europea

https://rarediseases.org/rare-diseases/whim-syndrome/. Consultato nell'aprile 20263. Badolato R, Alsina L, Azar A, et al. Studio randomizzato di fase 3 su mavorixafor, un antagonista CXCR4, per la sindrome WHIM. Sangue. 2024;144(1):35-454.

More news about: Norgine B.V.


Apr 30, 2026, 14:09 ET /C O R R E C T I O N -- Hippocratic AI/

More news about: Hippocratic AI


Apr 30, 2026, 13:59 ET Egan-Jones Recommends WEX Shareholders Support Impactive Nominees in 2026 Director Election

April 30, 2026 /PRNewswire/ -- Egan-Jones released an analysis recommending that WEX shareholders vote FOR Kurt P. Adams, Ellen R. Alemany, and Lauren Taylor Wolfe using the WHITE universal proxy card at the Company's May 5, 2026 Annual Meeting. Egan-Jones further recommends that

More news about: Egan-Jones Ratings Company


Apr 30, 2026, 13:00 ET Unlikely Collaborators Announces Continued Support of Dougy Center with New Two-Year Grant

here.Unlikely Collaborators is a nonprofit organization, founded and chaired by Elizabeth R. Koch, dedicated to fostering transformative storytelling, developing human connection, and resolving internal conflict. Unlikely Collaborators' perspective,

More news about: Unlikely Collaborators


Apr 30, 2026, 12:52 ET Capital Properties, Inc. Declares Regular Quarterly Dividend

locations along interstate and primary highways in Rhode Island and Massachusetts for outdoor advertising purposes. CONTACT:Susan R. Johnson, Treasurer401-435-7171

More news about: Capital Properties, Inc.


Apr 30, 2026, 12:47 ET Mairs & Power Growth Fund Returns to Its Original Name, the Mairs & Power Fund

to the original name reflects both the Fund's heritage and long-standing investment philosophy that has guided our approach for decades," said Andrew R. (Andy) Adams, Chief Investment Officer of Mairs & Power.The Fund will continue to trade under the same ticker (MPGFX) and CUSIP (89834G711).

More news about: Mairs & Power


Apr 30, 2026, 12:38 ET Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform

appointment of Annalisa Jenkins, M.B.B.S., F.R.C.P., as a Strategic Adviser. Dr. Jenkins brings over 25 years of biopharma leadership, spanning global R&D executive roles at major pharmaceutical companies, biotech CEO roles, membership on the U.S. FDA Science Board and a distinguished record of identifying

More news about: Northwest Biotherapeutics, Inc.


Apr 30, 2026, 12:30 ET Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform

appointment of Annalisa Jenkins, M.B.B.S., F.R.C.P., as a Strategic Adviser. Dr. Jenkins brings over 25 years of biopharma leadership, spanning global R&D executive roles at major pharmaceutical companies, biotech CEO roles, membership on the U.S. FDA Science Board and a distinguished record of identifying

More news about: Northwest Biotherapeutics, Inc.


Apr 30, 2026, 12:00 ET United Homes Group, Inc. (UHG) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

The Law Offices of Frank R. Cruz announces that investors with losses related to United Homes Group, Inc. ("United Homes" or the "Company") (NASDAQ:

More news about: The Law Offices of Frank R. Cruz, Los Angeles


Apr 30, 2026, 12:00 ET Medpace Holdings, Inc. (MEDP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

The Law Offices of Frank R. Cruz announces that investors with losses related to Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ:

More news about: The Law Offices of Frank R. Cruz, Los Angeles


Apr 30, 2026, 11:46 ET Global Enterprise Application Market Size to Reach USD 521.2 Billion by 2032, Fueled by Digital Transformation, Cloud Adoption, and Business Automation

Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.About

More news about: Verified Market Research


Apr 30, 2026, 11:37 ET INTCO Medical présente ses résultats pour 2025, affichant une croissance soutenue. Son chiffre d'affaires atteint son plus haut niveau depuis quatre ans alors que l'industrie se redresse

principaleLes gants jetables demeurent l'activité principale d'INTCO Medical. À la fin de l'année 2025, l'entreprise disposait de 10 bases de R&D et de fabrication dans le monde, dotées d'une capacité de production annuelle de gants jetables sans latex de 103 milliards de pièces, dont 70 milliards

More news about: INTCO MEDICAL


Apr 30, 2026, 11:34 ET Colossal Biosciences Expands De-extinction Portfolio with Iconic Bluebuck

We're committed to ensuring this project meets the highest standards of scientific rigor and regulatory compliance throughout the entire process."R. Alta Charo, Warren P. Knowles Professor Emerita of Law and Bioethics at the University of Wisconsin-Madison and an advisor to Colossal, has long argued

More news about: Colossal Biosciences Inc.


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.